Acro Biomedical Co., Ltd.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 293.6% | 293.6% | -1,714.5% |
| FY2017 | -0.4% | -0.4% | -0.4% |
| FY2018 | 35.9% | 35.9% | 28.3% |
| FY2019 | -46.6% | -46.6% | -39.9% |
| FY2020 | -17.1% | -17.1% | -11.8% |
| FY2021 | -1,195.9% | -1,195.9% | -1,011.4% |
| FY2022 | -3,263.2% | -3,263.2% | -2,308.6% |
| FY2023 | 3,426.9% | 3,426.9% | -15,066.2% |
| FY2024 | 14.3% | 14.3% | -132.3% |
| FY2025 | 26.1% | 26.1% | -717.4% |